TMED10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.493200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.359800E-01
Normal-vs-Stage2
3.264800E-01
Normal-vs-Stage3
7.900400E-01
Normal-vs-Stage4
2.420000E-01
Stage1-vs-Stage2
5.332000E-01
Stage1-vs-Stage3
3.909600E-01
Stage1-vs-Stage4
2.328400E-01
Stage2-vs-Stage3
1.370390E-01
Stage2-vs-Stage4
2.101400E-01
Stage3-vs-Stage4
1.229380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.270600E-01
Normal-vs-AfricanAmerican
4.546200E-01
Normal-vs-Asian
9.371600E-01
Caucasian-vs-AfricanAmerican
7.703200E-01
Caucasian-vs-Asian
4.716300E-02
AfricanAmerican-vs-Asian
3.085400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.433200E-01
Normal-vs-Female
3.712200E-01
Male-vs-Female
7.734600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.640000E-01
Normal-vs-Age(41-60Yrs)
1.822970E-01
Normal-vs-Age(61-80Yrs)
4.724800E-01
Normal-vs-Age(81-100Yrs)
4.431600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.017000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.206400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.649600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.120300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.039000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.952600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.494600E-01
Normal-vs-Daily Drinker
5.804600E-01
Normal-vs-Weekly Drinker
7.921400E-01
Normal-vs-Occasional Drinker
1.709180E-01
Normal-vs-Social Drinker
3.212200E-01
Non Drinker-vs-Daily Drinker
8.832600E-01
Non Drinker-vs-Weekly Drinker
6.091600E-01
Non Drinker-vs-Occasional Drinker
1.546340E-02
Non Drinker-vs-Social Drinker
2.334200E-01
Daily Drinker-vs-Weekly Drinker
5.889600E-01
Daily Drinker-vs-Occasional Drinker
4.950300E-02
Daily Drinker-vs-Social Drinker
3.706000E-01
Weekly Drinker-vs-Occasional Drinker
3.093900E-02
Weekly Drinker-vs-Social Drinker
1.924180E-01
Occasional Drinker-vs-Social Drinker
3.148600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.654830E-01
Normal-vs-Grade 2
2.348000E-02
Normal-vs-Grade 3
4.271500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.688400E-01
Grade 1-vs-Grade 3
6.402200E-01
Grade 1-vs-Grade 4
1.654830E-01
Grade 2-vs-Grade 3
1.606240E-01
Grade 2-vs-Grade 4
2.348000E-02
Grade 3-vs-Grade 4
4.271500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.690800E-01
Normal-vs-NonDiabetic
3.849200E-01
Diabetic-vs-NonDiabetic
7.759000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.223400E-01
Normal-vs-NoPancreatitis
3.489400E-01
Pancreatitis-vs-NoPancreatitis
9.595700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.779800E-01
Normal-vs-N1
2.986800E-01
N0-vs-N1
2.907600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.592770E-01
Normal-vs-TP53-NonMutant
3.532200E-01
TP53-Mutant-vs-TP53-NonMutant
1.152200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
